Atlas Trials

A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver Cirrhosis

Clinical trial NCT04088058 · UNKNOWN

Trial details

NCT number
NCT04088058
Sponsor
Gwo Xi Stem Cell Applied Technology Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Liver Cirrhosis
Start date
2019-11-16
Primary completion
2025-04-19
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.